Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch

Domenico Ribatti, Angelo Vacca

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Multiple myeloma (MM) mainly progresses in bone marrow (BM). Therefore, signals from the BM microenvironment are thought to play a critical role in maintaining plasma cell growth, migration, and survival. Reciprocal positive and negative interactions between plasma cells and microenvironmental cells, including endothelial cells (ECs) and fibroblasts may occur. The BM neovascularization is a constant hallmark of MM, and goes hand in hand with progression to leukemic phase. Microenvironmental factors induce MMECs and fibroblasts to become functionally different from monoclonal gammopathy of undetermined significance (MGUS) ECs (MGECs), i.e., to acquire an overangiogenic phenotype, and be similar to transformed cells. These alterations play an important role in MM progression and may represent new molecular markers for prognostic stratification of patients and prediction of response to antiangiogenic drugs, as well as new potential therapeutic targets.

Original languageEnglish
Title of host publicationCancer Treatment and Research
PublisherKluwer Academic Publishers
Pages51-61
Number of pages11
Volume169
DOIs
Publication statusPublished - 2016

Publication series

NameCancer Treatment and Research
Volume169
ISSN (Print)09273042

Fingerprint

Multiple Myeloma
Endothelial Cells
Fibroblasts
Bone Marrow
Plasma Cells
Monoclonal Gammopathy of Undetermined Significance
Cell Movement
Cell Survival
Phenotype
Growth
Pharmaceutical Preparations
Therapeutics

Keywords

  • Angiogenesis
  • Antiangiogenesis
  • Endothelial cells
  • Fibroblasts
  • Multiple myeloma

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Ribatti, D., & Vacca, A. (2016). Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch. In Cancer Treatment and Research (Vol. 169, pp. 51-61). (Cancer Treatment and Research; Vol. 169). Kluwer Academic Publishers. https://doi.org/10.1007/978-3-319-40320-5_5

Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch. / Ribatti, Domenico; Vacca, Angelo.

Cancer Treatment and Research. Vol. 169 Kluwer Academic Publishers, 2016. p. 51-61 (Cancer Treatment and Research; Vol. 169).

Research output: Chapter in Book/Report/Conference proceedingChapter

Ribatti, D & Vacca, A 2016, Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch. in Cancer Treatment and Research. vol. 169, Cancer Treatment and Research, vol. 169, Kluwer Academic Publishers, pp. 51-61. https://doi.org/10.1007/978-3-319-40320-5_5
Ribatti D, Vacca A. Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch. In Cancer Treatment and Research. Vol. 169. Kluwer Academic Publishers. 2016. p. 51-61. (Cancer Treatment and Research). https://doi.org/10.1007/978-3-319-40320-5_5
Ribatti, Domenico ; Vacca, Angelo. / Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch. Cancer Treatment and Research. Vol. 169 Kluwer Academic Publishers, 2016. pp. 51-61 (Cancer Treatment and Research).
@inbook{b2a67a5f55c94aa48a533845babc51cf,
title = "Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch",
abstract = "Multiple myeloma (MM) mainly progresses in bone marrow (BM). Therefore, signals from the BM microenvironment are thought to play a critical role in maintaining plasma cell growth, migration, and survival. Reciprocal positive and negative interactions between plasma cells and microenvironmental cells, including endothelial cells (ECs) and fibroblasts may occur. The BM neovascularization is a constant hallmark of MM, and goes hand in hand with progression to leukemic phase. Microenvironmental factors induce MMECs and fibroblasts to become functionally different from monoclonal gammopathy of undetermined significance (MGUS) ECs (MGECs), i.e., to acquire an overangiogenic phenotype, and be similar to transformed cells. These alterations play an important role in MM progression and may represent new molecular markers for prognostic stratification of patients and prediction of response to antiangiogenic drugs, as well as new potential therapeutic targets.",
keywords = "Angiogenesis, Antiangiogenesis, Endothelial cells, Fibroblasts, Multiple myeloma",
author = "Domenico Ribatti and Angelo Vacca",
year = "2016",
doi = "10.1007/978-3-319-40320-5_5",
language = "English",
volume = "169",
series = "Cancer Treatment and Research",
publisher = "Kluwer Academic Publishers",
pages = "51--61",
booktitle = "Cancer Treatment and Research",

}

TY - CHAP

T1 - Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch

AU - Ribatti, Domenico

AU - Vacca, Angelo

PY - 2016

Y1 - 2016

N2 - Multiple myeloma (MM) mainly progresses in bone marrow (BM). Therefore, signals from the BM microenvironment are thought to play a critical role in maintaining plasma cell growth, migration, and survival. Reciprocal positive and negative interactions between plasma cells and microenvironmental cells, including endothelial cells (ECs) and fibroblasts may occur. The BM neovascularization is a constant hallmark of MM, and goes hand in hand with progression to leukemic phase. Microenvironmental factors induce MMECs and fibroblasts to become functionally different from monoclonal gammopathy of undetermined significance (MGUS) ECs (MGECs), i.e., to acquire an overangiogenic phenotype, and be similar to transformed cells. These alterations play an important role in MM progression and may represent new molecular markers for prognostic stratification of patients and prediction of response to antiangiogenic drugs, as well as new potential therapeutic targets.

AB - Multiple myeloma (MM) mainly progresses in bone marrow (BM). Therefore, signals from the BM microenvironment are thought to play a critical role in maintaining plasma cell growth, migration, and survival. Reciprocal positive and negative interactions between plasma cells and microenvironmental cells, including endothelial cells (ECs) and fibroblasts may occur. The BM neovascularization is a constant hallmark of MM, and goes hand in hand with progression to leukemic phase. Microenvironmental factors induce MMECs and fibroblasts to become functionally different from monoclonal gammopathy of undetermined significance (MGUS) ECs (MGECs), i.e., to acquire an overangiogenic phenotype, and be similar to transformed cells. These alterations play an important role in MM progression and may represent new molecular markers for prognostic stratification of patients and prediction of response to antiangiogenic drugs, as well as new potential therapeutic targets.

KW - Angiogenesis

KW - Antiangiogenesis

KW - Endothelial cells

KW - Fibroblasts

KW - Multiple myeloma

UR - http://www.scopus.com/inward/record.url?scp=84989893416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989893416&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-40320-5_5

DO - 10.1007/978-3-319-40320-5_5

M3 - Chapter

AN - SCOPUS:84989893416

VL - 169

T3 - Cancer Treatment and Research

SP - 51

EP - 61

BT - Cancer Treatment and Research

PB - Kluwer Academic Publishers

ER -